Advertisement
ENOV vs HYPRF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a StrongBuy and HYPRF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green whileHYPRF’s FA Score has 0 green FA rating(s).
- ENOV’s FA Score: 0 green, 5 red.
- HYPRF’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 6 TA indicator(s) are bullish.
- ENOV’s TA Score: 6 bullish, 4 bearish.
Price Growth
ENOV (@Medical/Nursing Services) experienced а +2.40% price change this week, while HYPRF (@Industrial Machinery) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +4.30%. For the same industry, the average monthly price growth was +4.04%, and the average quarterly price growth was +10.75%.
The average weekly price growth across all stocks in the @Industrial Machinery industry was +3.27%. For the same industry, the average monthly price growth was +3.41%, and the average quarterly price growth was +22.33%.
Reported Earning Dates
ENOV is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Medical/Nursing Services (+4.30% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Industrial Machinery (+3.27% weekly)The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
| ENOV | HYPRF | ENOV / HYPRF | |
| Capitalization | 1.78B | 29.7M | 6,000% |
| EBITDA | -472.1M | -194.75M | 242% |
| Gain YTD | -28.965 | 0.000 | - |
| P/E Ratio | N/A | N/A | - |
| Revenue | 2.19B | 214M | 1,023% |
| Total Cash | 44.1M | 165M | 27% |
| Total Debt | 1.47B | 16.9M | 8,669% |
ENOV | ||
|---|---|---|
OUTLOOK RATING 1..100 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 96 | |
PRICE GROWTH RATING 1..100 | 61 | |
P/E GROWTH RATING 1..100 | 98 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ENOV | HYPRF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 50% | N/A |
| Stochastic ODDS (%) | 2 days ago 71% | N/A |
| Momentum ODDS (%) | 2 days ago 63% | N/A |
| MACD ODDS (%) | 2 days ago 70% | N/A |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 14% |
| TrendMonth ODDS (%) | 2 days ago 63% | 2 days ago 11% |
| Advances ODDS (%) | 15 days ago 60% | N/A |
| Declines ODDS (%) | 7 days ago 75% | N/A |
| BollingerBands ODDS (%) | 2 days ago 83% | N/A |
| Aroon ODDS (%) | 2 days ago 67% | N/A |
Advertisement
ENOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with IART. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then IART could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | +0.58% | ||
| IART - ENOV | 59% Loosely correlated | +3.43% | ||
| CNMD - ENOV | 58% Loosely correlated | +0.83% | ||
| FELE - ENOV | 56% Loosely correlated | +0.45% | ||
| DOV - ENOV | 55% Loosely correlated | +0.94% | ||
| ITGR - ENOV | 54% Loosely correlated | -0.30% | ||
More | ||||
HYPRF and
Correlation & Price change
A.I.dvisor indicates that over the last year, HYPRF has been closely correlated with DUERF. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if HYPRF jumps, then DUERF could also see price increases.
| Ticker / NAME | Correlation To HYPRF | 1D Price Change % | ||
|---|---|---|---|---|
| HYPRF | 100% | N/A | ||
| DUERF - HYPRF | 81% Closely correlated | N/A | ||
| DURYY - HYPRF | 39% Loosely correlated | N/A | ||
| WRTBY - HYPRF | 33% Poorly correlated | +0.79% | ||
| HSHZY - HYPRF | 27% Poorly correlated | N/A | ||
| ENOV - HYPRF | 21% Poorly correlated | +0.58% | ||
More | ||||